The results denoted that levels of four serum tumor markers (CEA, CYFRA21-1, SCCA, and CA125) of lung cancer patients were noticeably higher than those of healthy subjects, and the difference was statistically significant, as shown in Table 3. This evidence concerns the gene CEACAM5 and lung carcinoma.